Form 4: Emergent BioSolutions SVP William Hartzel Reports Acquisition of 15,000 Shares

William Hartzel, SVP of Bioservices at Emergent BioSolutions, reports acquiring 15,000 shares of common stock through restricted stock units.

Summary

• On July 11, 2024, William Hartzel, SVP of Bioservices at Emergent BioSolutions Inc., acquired 15,000 shares of common stock.
• These shares were obtained through restricted stock units (RSUs) granted under the company's Amended and Restated Stock Incentive Plan.
• The RSUs vest in a single installment on the first anniversary of the grant date, contingent upon continued service with the company.
• Each RSU represents the right to receive one share of Emergent BioSolutions Inc. common stock, subject to potential adjustments as per the grant agreement.
• Following the transaction, Hartzel beneficially owns 48,107 shares of Emergent BioSolutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating stock ownership changes, which can be seen as a positive sign of executive alignment with company goals, but doesn't inherently indicate strong positive or negative sentiment.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted stock units vest in one installment on the first anniversary of the grant date, assuming continued service with the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates that a company executive is increasing their stake in the company.

Key Dates